Clinical Trial

Efficacy of Satisens® in Reducing Emotional Eating

Study acronym: Satisens
Completed
View on ClinicalTrials.gov →
Summary
This study evaluates the efficacy of Satisens®, a dietary supplement composed of plant extracts, in reducing emotional eating and sweet cravings in healthy adults. The study will analyze hormonal, neurotransmitter, and inflammatory markers to understand the underlying mechanisms.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-18.
Status change: Not Yet Recruiting → Completed 2026-06-17
Trial Details
NCT Number NCT07079046
Lead Sponsor José Enrique de la Rubia Ortí, Ph
Collaborators: VINABAS FORMULATIONS SL
Conditions Emotional Eating, Overweight or Obesity, Hormonal Changes, Neurotransmitter Agents, Food Cravings, Appetite Regulation, Body Weight, Inflammation Biomarkers
Enrollment 84 participants
Start Date 2025-09-15
Primary Completion 2025-12-18 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-22